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AbsTrACT
Current methods for measuring intervention coverage 
for reproductive, maternal, newborn, and child health 
and nutrition (RMNCH+N) do not adequately capture the 
quality of services delivered. Without information on the 
quality of care, it is difficult to assess whether services 
provided will result in expected health improvements. We 
propose a six-step coverage framework, starting from 
a target population to (1) service contact, (2) likelihood 
of services, (3) crude coverage, (4) quality-adjusted 
coverage, (5) user-adherence-adjusted coverage and (6) 
outcome-adjusted coverage. We support our framework 
with a comprehensive review of published literature on 
effective coverage for RMNCH+N interventions since 
2000. We screened 8103 articles and selected 36 from 
which we summarised current methods for measuring 
effective coverage and computed the gaps between ‘crude’ 
coverage measures and quality-adjusted measures. Our 
review showed considerable variability in data sources, 
indicator definitions and analytical approaches for effective 
coverage measurement. Large gaps between crude 
coverage and quality-adjusted coverage levels were 
evident, ranging from an average of 10 to 38 percentage 
points across the RMNCH+N interventions assessed. We 
define effective coverage as the proportion of individuals 
experiencing health gains from a service among those 
who need the service, and distinguish this from other 
indicators along a coverage cascade that make quality 
adjustments. We propose a systematic approach for 
analysis along six steps in the cascade. Research to date 
shows substantial drops in effective delivery of care across 
these steps, but variation in methods limits comparability 
of the results. Advancement in coverage measurement will 
require standardisation of effective coverage terminology 
and improvements in data collection and methodological 
approaches.
InTroduCTIon
Monitoring intervention coverage, defined as 
the proportion of the population in need of 
a health intervention who receives it, is essen-
tial for tracking progress towards universal 
health coverage—an aim of Sustainable 
Development Goal 3. Although the coverage 
of many interventions along the continuum of 
care for women’s, children’s and adolescents’ 
health has increased in the past decade, there 
is increasing evidence that national coverage 
indicators may overstate the health benefits 
of the programme because of poor quality of 
services.1 2
Advancement in coverage measurement 
requires a shift from tracking ‘crude’ or 
‘contact’ coverage to effective coverage, 
accounting for the quality of services and 
their impact on people’s health. Crude 
coverage indicators provide no indication 
about the quality of interventions, whereas 
summary box
 ► Most reproductive, maternal, newborn, and child 
health and nutrition (RMNCH+N) intervention cover-
age indicators—the proportion of the population in 
need of an intervention that receives it—monitored 
for decades do not capture the quality of delivery of 
the interventions and therefore provide only weak 
links with actual health benefits received by the 
population in need.
 ► An increasing number of studies attempt to measure 
effective coverage indicators that also capture the 
quality of care and quantify the gaps between crude 
coverage and quality-adjusted measures.
 ► Our comprehensive review of the literature 
shows evidence of large coverage quality gaps in 
RMNCH+N, but the definitions, terminologies, ana-
lytical methodologies used vary widely, limiting the 
interpretability and comparability of the results.
 ► Building on previous frameworks and our review of 
current practices, we propose an organising frame-
work to harmonise terminologies and methodologi-
cal approaches for the measurement of a coverage 
cascade, and a definition of effective coverage as 
‘the proportion of individuals experiencing health 
gains from a service among those who need the 
service’.
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contact coverage simply captures contact with a provider 
as a proxy for adequate receipt of the needed service. 
In recent years, an increasing number of studies have 
quantified the alarming gaps between crude or contact 
coverage indicators and those that measure the receipt 
and benefits from high-quality services (effective coverage 
indicators).1–5
The definition and measurement of effective coverage 
varies between studies. There is a need for standard 
terminology and methods for coverage measurement. 
We propose a framework for the measurement of effec-
tive coverage, apply it in our systematic review of the liter-
ature and provide examples of how the framework can 
be operationalised for reproductive, maternal, newborn, 
and child health and nutrition (RMNCH+N).
A frAmework for meAsuremenT of effeCTIve CoverAge: 
THe CoverAge CAsCAde
In general, the term effective coverage incorporates not 
just receipt of services but also their quality. Quality of 
care comprises several domains traditionally organ-
ised into inputs (eg, service availability and whether a 
provider had access to needed equipment, diagnostics 
and medicines, referred to as readiness measures), the 
process of service delivery (eg, whether health providers 
followed protocols or standards of care) and outcomes, 
including health benefits as well as patient satisfaction.6 7 
Effective coverage literature has also included consider-
ation of patient’s adherence to recommended practices 
or treatment as an indication of quality care. Focusing 
on better health as the desired outcome of health system 
functioning, effective coverage has also alternatively 
been defined as ‘the fraction of potential health gain 
that is actually delivered to the population through the 
health system, given its capacity’.8 9 Finally, definitions of 
effective coverage vary across disciplines. For example, 
for food fortification programmes, effective coverage has 
been defined in some studies as the proportion of the 
population in need that uses the product with recom-
mended frequency and quantity.10
Building on the Tanahashi framework, we propose 
a cascade framework that defines (table 1) and organ-
ises the components of coverage in a stepwise fashion 
(figure 1).11 The framework can be used as a standard 
approach to identify (and quantify) the losses to poten-
tial health benefits that can occur at each step and to 
assess the current measurement practices and gaps for 
each step. Table 2 presents an illustration of data collec-
tion approaches used to capture information on each of 
the steps of the framework, the types of interventions that 
can be introduced to address challenges and examples of 
how to assess each step. While the cascade applies well to 
a population cohort moving through each step, with the 
measure of each conditional on the previous, there are 
exceptions where a step may be successfully realised even 
though the previous step was not achieved. For example, 
user adherence can occur even though the service was 
not provided according to standard. Adherence to a 
long-term contraceptive method may occur even though 
counselling during service provision did not follow all 
standards. Such cases would often be evident at the indi-
vidual level, but be less evident in population-based aggre-
gate measures of coverage. Consequently, cross-sectional 
measures of individual steps in the coverage cascade may 
yield results that are higher than the previous step if the 
steps are not nested within each other.
synTHesIs of effeCTIve CoverAge lITerATure
We reviewed the published literature since 2000 to 
support our framework for measuring dimensions of 
quality-adjusted or effective coverage. A total of 8103 
publications on coverage of RMNCH+N since the year 
2000 were obtained from PubMed and screened (see 
online supplementary appendix 1). In all, 36 papers were 
selected. To quantify the drop between contact coverage 
and quality-adjusted coverage, we retained the 32 papers 
that included both a measure of crude or contact 
coverage and a quality-adjusted coverage measure. We 
documented the methodological approaches applied 
and quantified the size of the gap between crude, quali-
ty-adjusted and effective coverage where possible.
Of the 32 retained articles, 31 were carried out between 
2010 and 2017, 22 since 2015. The bulk of the articles 
reviewed focused on antenatal care (ANC; 15 articles), 
nutrition (10 articles) and infancy (seven articles) 
(figure 2). Studies assessing coverage indicators for infant 
health dealt exclusively with immunisation while those for 
child health were either about treatment of child illness 
or use of bednets. Coverage of pre-pregnancy, birth and 
postnatal care interventions were the least documented. 
See online supplementary appendix 3 that includes full 
details of publications, interventions analysed and their 
target population and service contact, crude and qual-
ity-adjusted measures produced. Using our framework, 
we observed the following in different intervention areas:
 ► Few studies reported crude and adjusted coverage 
measures for interventions for the pre-pregnancy and 
birth periods. For pre-pregnancy, one study relied 
on use of modern contraceptives among women 
aged 15–49 years as crude measure and linked with 
a facility survey input measure to adjust for quality.12 
The other used a demand satisfied with modern 
contraception as crude measure and adjusted with 
adherence to standards of care based on direct obser-
vation at facilities.2 The two studies that reported on 
births relied on linking between household survey 
and facility or frontline worker surveys. Both used 
skilled birth attendant as crude coverage measure 
and adjusted with facility input measures to estimate 
the likelihood of service coverage.3 12 The only study 
that reported crude and quality-adjusted measures 
for postnatal care used recall-based information 
from household surveys to estimate quality-adjusted 
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Figure 1 Hypothetical cascade of the potential losses of healthbenefits of interventions among a population in need of a 
specific healthservice.
coverage measures based on single or a combination 
of postnatal care interventions received.3
 ► Most analyses of ANC have relied on women’s recall 
of number of ANC visits and selected interventions 
received to measure service contact and crude 
coverage or quality-adjusted coverage and the gap 
between these two measures.1–4 13–21 Other studies 
have linked household surveys with facility surveys. 
These allow measurement of the drop between crude 
coverage and the likelihood of service, and quality-ad-
justed coverage using data on observations of clinical 
care.1 2 20 21
 ► For immunisation during infancy, crude coverage 
measures were based on vaccination information 
from recall or cards from household survey. Qual-
ity-adjusted coverage included serological tests to 
detect specific vaccine-related antibodies.22–26 One 
study adjusted the recall/card-based immunisation 
coverage measure with facility-level inputs to estimate 
the quality measure and another study considered 
timeliness and card availability.12 27
 ► Five studies analysed childhood interventions focusing 
on care seeking and treatment for child illness such 
as diarrhoea, fever and symptoms of acute respira-
tory infection, and use of insecticide-treated bednets. 
In addition to careseeking coverage, three of these 
studies measured process-adjusted coverage from 
recall of procedures and treatment received.12 28 29 
Two studies linked household and facility surveys to 
measure input-adjusted coverage or process-adjusted 
coverage.2 12 One study carried out blood testing for 
Plasmodium falciparum to compare with the use of 
long-lasting insecticide-treated bednets.30
 ► Nutrition publications were mostly small-scale studies 
relying predominantly on recall of food consump-
tion by women and children.10 31–36 Crude coverage 
was measured through consumption of/exposure to 
a particular fortified food; quality-adjusted measures 
were based on regular consumption of the fortified 
food, a user-adjusted coverage measure. One study 
reported on breast feeding among children under 6 
months and another on home fortification with micro-
nutrient powder among children 6–59 months.12 37
meTHods for meAsurIng effeCTIve CoverAge In 
rmnCH+n
This review of effective coverage analyses showed consid-
erable variability in study methods, including data sources, 
indicator definitions and analytical approaches, and not 
always consistent with the logical flow of our proposed 
framework (see online supplementary appendix 2). The 
greatest consistency was the source of data for defining 
intervention target population: one analysis employed 
a population cohort from a demographic surveillance 
site, whereas all others used cross-sectional household 
surveys, either programme specific or standard surveys 
such as Demographic and Health Survey (DHS) or 
Multiple Indicator Cluster Survey (MICS). Definitions of 
target population varied subtly; for instance, the recall 
period for women in need of ANC varied from currently 
pregnant to live birth in the past 5 years.17 35 Eligibility 
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of children for effective coverage of child health services 
depended on the intervention and was sometimes based 
on age alone (eg, vaccination) or age as well as illness; 
some studies of nutrition limited the definition of those 
in need to children in poverty with poor diet diversity 
or suboptimal feeding practices.32 34 In measuring inter-
vention coverage, the majority of studies relied on the 
same data source as in defining the target population 
and elicited self-reports of healthcare use (care seeking) 
or health commodity use (ie, treatment, contraceptive, 
supplemented food product). The exception was use of 
geospatial information on households and facilities to 
estimate geographical access to health facilities within 5 
km of recently pregnant women.19
The largest variation in methods was observed in 
estimates of quality-adjusted estimates. Three types of 
data sources were used: self-report via the same popu-
lation-based survey used for defining crude coverage, 
assessment of specimen samples collected during the 
survey (eg, blood titre for antibody response, food spec-
imen for micronutrient concentration) and a separate 
sample of health facilities or, in one case, food available 
at local markets. Indicators of quality differed across 
nearly every study and included binary indicators of 
receipt of a single service (positive antibody titres, self-re-
ported health commodity use), binary indicators of 
multiple elements (facility with resources required for 
quality, visit with most/all essential elements of evidence-
based care included), and, least commonly, proportions 
of care available or delivered (adherence to evidence-
based guidelines, proportion of necessary resources 
available in facility). Analytic approaches differed for 
studies linking individuals surveyed in households to 
external information such as health facility assessments: 
three studies linked individuals to facilities directly using 
health records,20 linear distance19 or cluster bound-
aries.7 All others relied on ecological linkages between 
summaries of access to care and quality of care stratified 
by region and/or facility characteristics, with little consis-
tency in choice of strata. Calculation of variance around 
quality-adjusted coverage estimates was similarly hetero-
geneous. Studies relying on a single population survey 
for all indicators typically calculated variance following 
survey sample methods. Those combining sources most 
often reported no variance for effective coverage calcula-
tion. One study employed a Taylor series expansion12 and 
one the exact variance of a product.2
gAp beTween Crude CoverAge And quAlITy-AdjusTed 
CoverAge
Figure 3 shows the average percentage point gaps 
between contact or crude measures and adjusted meas-
ures along the continuum of care. Studies have mostly 
measured two or three steps of the cascade, usually a 
contact indicator followed by an input-adjusted indicator 
or the likelihood of care, or crude coverage indicator 
and a quality-adjusted measure. Only studies assessing 
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Figure 2 Distribution of publications by component of thecontinuum of care.
Figure 3 Average percentage points gap between contact or crudecoverage and adjusted coverage measures.
effective coverage of immunisation of infants included 
measures of outcome-adjusted coverage, measured using 
serological tests, independent from the crude coverage 
measure. Figure 3 demonstrates the evidence of a large 
drop in coverage when some measure of quality is used, 
ranging from an average percentage point drop of 10 
to 38 points. The evidence suggests large variability 
in the size of the drop across the continuum of care. 
It also depends on the type of adjustment made, the 
indicators used and whether the baseline indicator is a 
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contact indicator (eg, care seeking for treatment of child 
illness) or a crude coverage (measles vaccination). For 
ANC and nutrition, there were measures for which the 
gaps between contact or crude coverage and the quali-
ty-adjusted coverage were over 90 percentage points but 
also some measures which show higher quality-adjusted 
coverage than crude coverage. This is the case for immu-
nisation of infants where serological tests resulted in 
higher coverage than the crude recall-based coverage. 
This may be the result of a measurement artefact as for 
example, in cases which compared ANC4+ as a crude 
coverage measure to coverage of receipt of one or a set of 
interventions during ANC as a quality-adjusted measure. 
Coverage of receipt of an intervention during ANC as 
measured through women’s recall may be higher than 
ANC4+.
key CHAllenges meAsurIng effeCTIve CoverAge
In the absence of a standard organising framework to 
guide the measurement of coverage indicators that adjust 
for quality dimensions, researchers have developed their 
own methods and adjustment approaches, focusing on 
specific components of quality of care, often relying 
on WHO-recommended standards for care provision.2 
Building on previous attempts at developing a framework 
for effective coverage, such as the Tanahashi’s model, we 
propose a framework for measuring effective coverage 
in RMNCH+N that presents a cascade of potential loss 
of effectiveness of an intervention from contact with a 
health provider to effective coverage.11 We considered 
effective coverage as outcome-based coverage: proportion 
of individuals experiencing optimal health gains from a 
service among those who need the service. Our proposed 
framework contributes to harmonising the various defi-
nitions and terminologies of effective coverage currently 
used inconsistently in the scientific literature while main-
taining the focus on impact in RMNCH+N.
Advancement in coverage measurement faces 
numerous challenges, reflected in the studies reviewed. 
Although these studies generally show a substantial drop 
in coverage when comparing contact or crude coverage 
to quality-adjusted measures, definitions, methods and 
approaches used are heterogeneous and inconsistent. 
Quality of care is a multidimensional construct that 
includes inputs, processes and outcomes and experi-
ence of care from the patient perspective. Due to lack 
of consensus on measurement, the operational defini-
tion used to assess measures that adjust for quality mostly 
depends on available data and study objectives. There are 
currently few standards in items or procedures, in terms 
of their composition and number, included in quality 
adjustment, whether for inputs, processes or outcomes. 
Studies have considered either single interventions and/
or a combination of procedures using simple arithmetic 
averages. Thus, measures that adjust for quality, and 
therefore the gap between crude coverage and effective 
coverage, do not compare from one study to another. 
Similarly, for studies that have combined household and 
facility survey data to derive adjusted measures, there 
are no standard approaches for linking these datasets. 
Some studies have used geocoordinates for an ecological 
linkage, whereas others have used the type of facility and/
or administrative area.1 2 In addition, there is substantial 
variation in the temporal gaps between household and 
facility assessments, in the sampling design of the facility 
assessment, and in the weighting of facility data for linked 
analyses.
Current studies have in most cases been opportunistic, 
often relying on secondary data from household inter-
views and facility surveys. Studies that have used primary 
standalone data collection were often of small scale, 
covering few districts. Consequently, each stage of the 
continuum of care for RMNCH+N is not equally covered, 
nor are all steps of the cascade framework captured. The 
area most covered is ANC due to widely available data 
on ANC content from household and facility surveys. 
No study assessed whether adjusting for dimensions of 
quality was associated with impact or with loss of effec-
tiveness or impact.
The proposed cascade framework offers an organising 
approach for improving consistency and definitions 
across studies attempting to measure quality-adjusted 
coverage, as well as the interpretation on these measures. 
Although the cascade approach is intuitive for most 
interventions or packages of interventions, there may be 
situations where the coverage measures do not decrease 
monotonically along the steps. This is mainly the case for 
user-adjusted adherence, which can occur even though 
services were not delivered according to standard. In 
such cases, independent serial cross-sectional coverage 
measures at each step may not decrease along the steps. 
Such issue will, however, disappear when the coverage 
measure of each step effectively depends on the realisa-
tion of previous steps.
wAy forwArd for effeCTIve CoverAge meAsuremenT
Biomarkers and cohort registration approaches are 
central in the cascade frameworks used in programmes for 
the prevention of mother to child HIV transmission, HIV 
antiretroviral treatment and tuberculosis diagnosis and 
treatment.38–42 Biomarkers are used to assess the popu-
lation in need and to measure outcomes of interest such 
as HIV viral load suppression. In immunisation, disease 
incidence is the main outcome interest, but seroconver-
sion rates are used as a measure of a biological outcome 
of services and thus measure effective coverage.25 In 
maternal and newborn health programmes, biomarkers 
and cohort approaches are less common and effective 
coverage is often defined in terms of quality-adjusted 
coverage measures, based on the contents of services and 
the extent to which services were delivered according to 
standards. Cohort approaches in the context of mater-
nity care can provide outcome data related to service 
provision. In other cases, new approaches that include 
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multiple indicators and analytical methods to assess the 
health gains such as combining population survey data 
with health facility data including health outcomes such 
as institutional perinatal mortality rates should be tested.
Three critical recommendations stem out of our review. 
First, terminologies and definitions used for monitoring 
effective coverage must be standardised and harmonised 
across the RMNCH+N at global level and within the scien-
tific community. Only then will the coverage cascade and 
effective coverage measures be more easily interpreted, 
meta-analysed and communicated to countries resulting 
in policy and programmatic action. Our proposed frame-
work, which is sufficiently broad and applicable to all 
components of the RMNCH continuum, offers such 
standardisation.
Second, measuring each step on the framework will 
require improvements in data collection at both house-
hold and facility levels, as well as investment in stable 
national and subnational surveillance systems. Measuring 
populations in need from household surveys will require 
innovations in data collection, including for example 
biomarkers. Data sources for estimating coverage at 
national, regional and global levels have relied mainly on 
national household surveys, driven primarily by the DHSs 
initiated in the mid-1980s and the MICSs implemented 
since mid-1990s.43 44 Although the size of the question-
naires used by these programme has grown substantially 
over time, limited progress has been made in indicator 
development for RMNCH+N coverage, and most indica-
tors have been measured in the same way for the past 
20–30 years.45 Furthermore, more rigorous validation 
of household survey-based RMNCH+N content indi-
cators using either observation of service delivery and 
follow-up recall interviews with women or biomarkers in 
some cases has uncovered inaccuracy in some key indi-
cators.46–49 Recall-based household interviews do not 
measure correctly most interventions delivered during 
intrapartum care.49 Similarly, some indicators of treat-
ment for childhood illnesses measured in household 
surveys (antibiotics for symptoms of pneumonia, antima-
larial for fever) have been proven invalid for monitoring 
coverage of these treatment interventions.50–52 Improved 
measurement of service contact, likelihood of service 
and quality-adjusted coverage measures will also require 
investment in improving facility data, both routine health 
system information and standalone health facility surveys, 
developing best approaches for collecting linked data. 
There are also major gaps in measuring user adherence 
and client experience services, which will require special 
innovative approaches.
Third, approaches that link household-based data 
with health facility data are increasingly popular, but 
priority must also be given to analytical techniques for 
the linking and computation of valid measures of effec-
tive coverage.53 The few studies that have implemented 
such linking have used ecological linking and relied 
on existing data such as DHS and Service Provision 
Assessment (SPA) or Service Availability and Readiness 
Assessment (SARA) surveys to estimate quality-adjusted 
coverage measures.1 2 Those that have used primary data 
were at small scale.3 54 The linking was implemented 
using geocoordinate data or facility type disaggregated by 
urban/rural location. Furthermore, variance and preci-
sion of coverage indicators derived from linked data are 
yet to be fully understood.
While the evidence based on methods for effective 
coverage measurement must be expanded, it is critical that 
the global community, including national data collection 
programmes such as DHS, MICS, SARA, SPA, prioritises 
reporting of each step of the proposed cascade frame-
work in RMNCH+N. Measurement to better monitor, 
understand and act on the gaps in effective coverage is 
required to make significant progress towards universal 
health coverage with quality services for women’s and 
children’s health.
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